Top

Current Pulmonology Reports

21-02-2024 | Lung Cancer | REVIEW

Onco-Pulmonology: Exploring a New Frontier in Pulmonary Medicine

Authors: Isaac Laniado, Antonio Velez, Daniel H. Sterman

Published in: Current Pulmonology Reports

Abstract

Purpose of Review

To detail the proposed skills and roles of an onco-pulmonologist.

Recent Findings

Lung cancer remains the leading cause of cancer-related death in the USA, and it requires a comprehensive multidisciplinary approach to care, which can be affected in some cases by an imbalance of patients and available providers. While pulmonologists traditionally have played an important role in screening, prevention, diagnosis, and palliation of symptoms, training in onco-pulmonology has been proposed to help bridge the gaps in lung cancer care.

Summary

The onco-pulmonologist should be well versed in advanced diagnostic bronchoscopy and pleural procedures. Additionally, the onco-pulmonologist should have an in-depth knowledge of primary cancer therapies for thoracic malignancies and should be able to recognize and treat all common treatment-related toxicities. Ultimately, the onco-pulmonologist may serve in leadership roles at cancer centers including dedicated lung cancer screening programs and lung nodule surveillance.

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.CrossRefPubMed

Zhao X, Wen X, Wei W, Chen Y, Zhu J, Wang C. Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors. Oncotarget. 2017;8(28):46491–7.CrossRefPubMedPubMedCentral

American Medical Association. AMA Physician Masterfile (Website: https://www.aamc.org/data-reports Dec. 31, 2021).

Gaga M, Powell CA, Schraufnagel DE, Schönfeld N, Rabe K, Hill NS, Sculier JP. ATS/ERS task force on the role of the pulmonologist in the management of lung cancer. An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer. Am J Respir Crit Care Med. 2013;188(4):503–7. https://doi.org/10.1164/rccm.201307-1269ST.

• Tandon S, Biraris P, Bhaskar M. ‘Pulmonary oncologist—an idea whose time has come?’, Indian J Med Paediatr Oncol. 2022;43(01):095–096. https://doi.org/10.1055/s-0042-1742638. Authors in this study highlight the need for a multidisciplinary approach to lung cancer care, especially in settings with significant shortage of medical oncologists. Training in pulmonary oncology is proposed to increase patient outreach and help close the gaps in care.

•• Tandon S, Biraris P, Bhaskar M. Pulmonary oncology-scope of the pulmonologist. Indian J Med Paediatr Oncol. 2022;43:29–33. https://doi.org/10.1055/s-0042-1742653. Authors in this study propose a set of skills that help define the role of a pulmonary oncologist. These remarks are based on the authors’ experience from a first of its kind 2-year training program in pulmonary oncology at their institution.

Dülger S, Doğan C, Dikiş ÖŞ, Yıldırım E, Tapan U, Özmen İ, Satılmış BŞ, İntepe YS, Ocaklı B, Kaçan CY, Budak E, Yıldız T. Analysis of the role of physicians in the cessation of cigarette smoking based on medical specialization. Clinics (Sao Paulo). 2018;73: e347. https://doi.org/10.6061/clinics/2018/e347.CrossRefPubMed

Lim G, Park I, Park S, Song S, Kim H, Kim S. Effectiveness of smoking cessation using motivational interviewing in patients consulting a pulmonologist. Tuberc Respir Dis (Seoul). 2014;76(6):276–83. https://doi.org/10.4046/trd.2014.76.6.276.CrossRefPubMed

National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395–409. https://doi.org/10.1056/NEJMoa1102873.

10.

Criss SD, Cao P, Bastani M, Ten Haaf K, Chen Y, Sheehan DF, Blom EF, Toumazis I, Jeon J, de Koning HJ, Plevritis SK, Meza R, Kong CY. Cost-effectiveness analysis of lung cancer screening in the United States: a comparative modeling study. Ann Intern Med. 2019;171(11):796–804. https://doi.org/10.7326/M19-0322.CrossRefPubMed

11.

• Smith HB, Ward R, Frazier C, Angotti J, Tanner NT. Guideline-recommended lung cancer screening adherence is superior with a centralized approach. Chest. 2022;161(3):818–825. https://doi.org/10.1016/j.chest.2021.09.002. Findings from this study highlight the improved screening ability and increased adherence to lung cancer screening programs with a centralized approach.

12.

Nadig TR, Thomas N, Nietert PJ, Lozier J, Tanner NT, Wang Memoli JS, Pastis NJ, Silvestri GA. Guided bronchoscopy for the evaluation of pulmonary lesions: an updated meta-analysis. Chest. 2023;163(6):1589–98. https://doi.org/10.1016/j.chest.2022.12.044.CrossRefPubMed

13.

Vu LH, Yu Lee-Mateus A, Edell ES, Hartley C, Vierkant RA, Fernandez-Bussy S, Reisenauer J. Accuracy of preliminary pathology for robotic bronchoscopic biopsy. Ann Thorac Surg. 2022;S0003–4975(22):01501–6. https://doi.org/10.1016/j.athoracsur.2022.11.022.CrossRef

14.

Duke JD, Reisenauer J. Robotic bronchoscopy: potential in diagnosing and treating lung cancer. Expert Rev Respir Med. 2023;17(3):213–21. https://doi.org/10.1080/17476348.2023.2192929.CrossRefPubMed

15.

Wagh A, Ho E, Murgu S, Hogarth DK. Improving diagnostic yield of navigational bronchoscopy for peripheral pulmonary lesions: a review of advancing technology. J Thorac Dis. 2020;12(12):7683–7690. https://doi.org/10.21037/jtd-2020-abpd-003.

16.

Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Cardillo G, Maskell NA. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52(1):1800349. https://doi.org/10.1183/13993003.00349-2018.CrossRefPubMed

17.

American Association for Bronchology and Interventional Pulmonology. Proposal for ACGME Recognition of a New Sub-subspecialty in Interventional Pulmonary Medicine (Website: https://www.acgme.org/globalassets/pfassets/proposalreviewandcomment/interventional-pulm---new-sub-proposal.pdf).

18.

Gaga M, Sculier JP, Rabe KF. Pulmonologists and lung cancer: pivotal role in multidisciplinary approach. Eur Respir J. 2013;42(5):1183–5. https://doi.org/10.1183/09031936.00145813.CrossRefPubMed

19.

Shankar B, Zhang J, Naqash AR, Forde PM, Feliciano JL, Marrone KA, Ettinger DS, Hann CL, Brahmer JR, Ricciuti B, Owen D, Toi Y, Walker P, Otterson GA, Patel SH, Sugawara S, Naidoo J. Multisystem immune-related adverse events associated with immune checkpoint inhibitors for treatment of non-small cell lung cancer. JAMA Oncol. 2020;6(12):1952–6. https://doi.org/10.1001/jamaoncol.2020.5012.CrossRefPubMed

20.

Zhang X, Lin D, Pforsich H, Lin VW. Physician workforce in the United States of America: forecasting nationwide shortages. Hum Resour Health. 2020;18(1):8. https://doi.org/10.1186/s12960-020-0448-3.CrossRefPubMedPubMedCentral

21.

Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4(4): e214708. https://doi.org/10.1001/jamanetworkopen.2021.4708.CrossRefPubMedPubMedCentral

Title: Onco-Pulmonology: Exploring a New Frontier in Pulmonary Medicine
Authors: Isaac Laniado
Antonio Velez
Daniel H. Sterman
Publication date: 21-02-2024
Publisher: Springer US
Keywords: Lung Cancer
Lung Cancer
Lung Cancer
Bronchoscopy
Published in: Current Pulmonology Reports
Electronic ISSN: 2199-2428
DOI: https://doi.org/10.1007/s13665-024-00342-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com